Round Hill Asset Management Amgen Inc Transaction History

Round Hill Asset Management

$138 Million
Q4 2024

A detailed history of Round Hill Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Round Hill Asset Management holds 44,748 shares of AMGN stock, worth $13.8 Million. This represents 8.48% of its overall portfolio holdings.

Number of Shares

44,748

Previous 44,319 0.97%

Holding current value

$13.8 Million

Previous $14.3 Million 18.33%

% of portfolio

8.48%

Previous 9.72%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$258.78 - $328.31 $111,016 - $140,844	429 Added 0.97%	44,748 $11.7 Million
Q3 2024 Nov 12, 2024	SELL	$309.38 - $337.38 $1.16 Million - $1.26 Million	-3,741 Reduced 7.78%	44,319 $14.3 Million
Q2 2024 Aug 12, 2024	SELL	$262.75 - $319.31 $440,631 - $535,482	-1,677 Reduced 3.37%	48,060 $15 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $240,638 - $290,481	-895 Reduced 1.77%	49,737 $14.1 Million
Q4 2023 Feb 12, 2024	SELL	$255.7 - $288.46 $292,776 - $330,286	-1,145 Reduced 2.21%	50,632 $14.6 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $292,991 - $363,756	-1,340 Reduced 2.52%	51,777 $13.9 Million
Q2 2023 Aug 11, 2023	SELL	$214.27 - $253.37 $113,991 - $134,792	-532 Reduced 0.99%	53,117 $11.8 Million
Q1 2023 May 11, 2023	SELL	$225.79 - $275.2 $359,006 - $437,568	-1,590 Reduced 2.88%	53,649 $13 Million
Q4 2022 Feb 10, 2023	SELL	$229.03 - $291.01 $170,398 - $216,511	-744 Reduced 1.33%	55,239 $14.5 Million
Q3 2022 Nov 10, 2022	SELL	$224.46 - $253.15 $50,279 - $56,705	-224 Reduced 0.4%	55,983 $12.6 Million
Q2 2022 Aug 11, 2022	SELL	$230.71 - $256.74 $39,451 - $43,902	-171 Reduced 0.3%	56,207 $13.7 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $39,468 - $43,662	180 Added 0.32%	56,378 $13.6 Million
Q4 2021 Feb 11, 2022	SELL	$198.88 - $227.6 $17,899 - $20,484	-90 Reduced 0.16%	56,198 $12.6 Million
Q3 2021 Nov 12, 2021	SELL	$212.27 - $248.7 $110,380 - $129,324	-520 Reduced 0.92%	56,288 $12 Million
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $25,693 - $28,505	-110 Reduced 0.19%	56,808 $13.9 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $22,412 - $26,118	-101 Reduced 0.18%	56,918 $14.2 Million
Q4 2020 Feb 12, 2021	SELL	$216.38 - $257.67 $30,293 - $36,073	-140 Reduced 0.24%	57,019 $13.1 Million
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $150,176 - $167,008	-640 Reduced 1.11%	57,159 $14.5 Million
Q2 2020 Aug 13, 2020	SELL	$197.81 - $242.74 $344,189 - $422,367	-1,740 Reduced 2.92%	57,799 $13.6 Million
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $191,352 - $253,785	-1,050 Reduced 1.73%	59,539 $12.1 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $121,283 - $155,891	-641 Reduced 1.05%	60,589 $14.6 Million
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $19,848 - $23,782	-114 Reduced 0.19%	61,230 $11.8 Million
Q2 2019 Aug 13, 2019	SELL	$166.7 - $195.41 $8,501 - $9,965	-51 Reduced 0.08%	61,344 $11.3 Million
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $143,791 - $162,084	-795 Reduced 1.28%	61,395 $11.7 Million
Q4 2018 Feb 14, 2019	SELL	$178.4 - $208.25 $128,804 - $150,356	-722 Reduced 1.15%	62,190 $12.1 Million
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $48,916 - $55,146	264 Added 0.42%	62,912 $13 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $357,837 - $401,929	-2,155 Reduced 3.33%	62,648 $11.7 Million
Q1 2018 May 15, 2018	SELL	$169.43 - $198.0 $255,839 - $298,980	-1,510 Reduced 2.28%	64,803 $11 Million
Q4 2017 Feb 13, 2018	SELL	$168.79 - $188.59 $73,423 - $82,036	-435 Reduced 0.65%	66,313 $11.5 Million
Q3 2017 Nov 13, 2017	BUY	$167.29 - $191.0 $11.2 Million - $12.7 Million	66,748	66,748 $12.4 Million

Others Institutions Holding AMGN

# of Institutions

3,172

Shares Held

419M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $165B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Round Hill Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Round Hill Asset Management with notifications on news.

Account

Round Hill Asset Management Amgen Inc Transaction History